1. Home
  2. POM vs MRVI Comparison

POM vs MRVI Comparison

Compare POM & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$0.35

Market Cap

555.4M

ML Signal

N/A

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.31

Market Cap

449.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POM
MRVI
Founded
2015
2014
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
555.4M
449.6M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
POM
MRVI
Price
$0.35
$3.31
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$4.57
AVG Volume (30 Days)
6.4M
1.2M
Earning Date
12-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$51,210,721.00
$192,435,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.04
P/E Ratio
N/A
N/A
Revenue Growth
12.13
N/A
52 Week Low
$0.26
$1.67
52 Week High
$6.43
$6.21

Technical Indicators

Market Signals
Indicator
POM
MRVI
Relative Strength Index (RSI) N/A 43.10
Support Level N/A $3.44
Resistance Level N/A $3.59
Average True Range (ATR) 0.00 0.19
MACD 0.00 -0.05
Stochastic Oscillator 0.00 5.15

Price Performance

Historical Comparison
POM
MRVI

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: